CA2868479A1 - Method for treatment of labor arrest - Google Patents

Method for treatment of labor arrest Download PDF

Info

Publication number
CA2868479A1
CA2868479A1 CA2868479A CA2868479A CA2868479A1 CA 2868479 A1 CA2868479 A1 CA 2868479A1 CA 2868479 A CA2868479 A CA 2868479A CA 2868479 A CA2868479 A CA 2868479A CA 2868479 A1 CA2868479 A1 CA 2868479A1
Authority
CA
Canada
Prior art keywords
chemically modified
heparan sulfate
modified heparin
heparin
labor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2868479A
Other languages
English (en)
French (fr)
Inventor
Gunvor Ekman-Ordeberg
Anders Malmstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dilafor AB
Original Assignee
Dilafor AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor AB filed Critical Dilafor AB
Publication of CA2868479A1 publication Critical patent/CA2868479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA2868479A 2012-03-26 2013-03-25 Method for treatment of labor arrest Abandoned CA2868479A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
US61/615,400 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (1)

Publication Number Publication Date
CA2868479A1 true CA2868479A1 (en) 2013-10-03

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2868479A Abandoned CA2868479A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Country Status (15)

Country Link
US (1) US20150057226A1 (enExample)
EP (1) EP2830634A4 (enExample)
JP (1) JP2015514705A (enExample)
CN (1) CN104244957B (enExample)
AU (1) AU2013240598A1 (enExample)
CA (1) CA2868479A1 (enExample)
HK (1) HK1203370A1 (enExample)
MX (1) MX2014011451A (enExample)
MY (1) MY185108A (enExample)
NZ (1) NZ631279A (enExample)
RU (1) RU2014143008A (enExample)
SG (1) SG11201406118QA (enExample)
UA (1) UA117907C2 (enExample)
WO (1) WO2013147690A1 (enExample)
ZA (1) ZA201406567B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2794665T3 (da) 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
MY169816A (en) 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
US20150099703A1 (en) * 2012-05-08 2015-04-09 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
US12502403B2 (en) 2020-02-17 2025-12-23 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
CN120603543A (zh) * 2023-02-01 2025-09-05 马特纳医疗公司 用于防止分娩期间阴道撕裂伤的方法和设备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
DK2794665T3 (da) * 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf

Also Published As

Publication number Publication date
CN104244957A (zh) 2014-12-24
RU2014143008A (ru) 2016-05-20
UA117907C2 (uk) 2018-10-25
JP2015514705A (ja) 2015-05-21
CN104244957B (zh) 2017-11-17
AU2013240598A1 (en) 2014-10-02
SG11201406118QA (en) 2014-11-27
EP2830634A1 (en) 2015-02-04
US20150057226A1 (en) 2015-02-26
EP2830634A4 (en) 2016-01-20
HK1203370A1 (en) 2015-10-30
WO2013147690A1 (en) 2013-10-03
MY185108A (en) 2021-04-30
ZA201406567B (en) 2017-06-28
MX2014011451A (es) 2014-11-10
NZ631279A (en) 2016-06-24

Similar Documents

Publication Publication Date Title
US20150057226A1 (en) Method for treatment of labor arrest
KR102135485B1 (ko) 반복 다이사카라이드 단위를 포함하는 비-항응고 글리코스아미노글리칸 및 이의 의학적 용도
US8524688B2 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
CN104203256B (zh) 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗
US20150099703A1 (en) Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190326